Company environment · Targeted small molecules · FDA CDER
A targeted cancer pill, filing by filing
Repeated filings: the original application and later expansions. Start at the top to see what the company does, then the jobs AI models were given here and how each scored.
1What does this company do?
A drug company with a targeted pill for rare cancers.
The pill was first approved for one rare tumor, then filed again for other related diseases.
2Where is the product on its way to patients?
Each job is a filing about to be locked and sent to the FDA.
- 1Discovery
- 2Lab & animal studies
- 3Human trials
- 4Filing & review
- The product is here
- 5Approved
- 6On the market
Every filing has a “freeze”: after it, the documents go out as they are. The clinical results, the label and the quality records must agree before then.
3What is happening right now?
A filing freezes today, and the working documents don’t agree.
The team must decide which study population, analysis and document version govern each claim, and keep later developments out of earlier decisions.
4Which jobs were the models given?
5 jobs, each graded against a specialist’s checklist.
Scores are checks passed out of checks in the list. Each model ran each job once.
5–7Evidence, work and verdict
This company’s files stay private.
It is built from a real product’s records, so its files, runs and checklists aren’t published. To follow a job all the way down to each check, open one of the public environments.
Havenor Therapeutics (fictional, fully published) →
Broad Institute (real, public FDA record) →